The anti-apoptotic gene Anamorsin is essential for both autonomous and extrinsic regulation of murine fetal liver hematopoiesis

Experimental Hematology

Volumn 42, Issue 5, 2014, Pages 410-422.e4

  Tanimura, Akira ^a   Shibayama, Hirohiko ^a   Hamanaka, Yuri ^a   Fujita, Natsuko ^a   Ishibashi, Tomohiko ^a   Sudo, Takao ^a   Yokota, Takafumi ^a   Ezoe, Sachiko ^a   Tanaka, Hirokazu ^b   Matsumura, Itaru ^b   Oritani, Kenji ^a   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMORSIN GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FEMALE; FETUS; FETUS LIVER; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LIVER CELL CULTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; STROMA CELL; WILD TYPE;

ANIMALS; FETUS; HEMATOPOIESIS, EXTRAMEDULLARY; HEMATOPOIETIC STEM CELLS; INHIBITOR OF APOPTOSIS PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MICE; MICE, KNOCKOUT;

EID: 84901027142     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2014.01.002     Document Type: Article

References (40)

1. Shibayama H., Takai E., Matsumura I., et al. Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis. J Exp Med 2004, 199:581-592.
2. Mantel C., Guo Y., Lee M.R., et al. Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability. Blood 2007, 109:4518-4527.
3. Li X., Wu K., Fan D. CIAPIN1 as a therapeutic target in cancer. Expert Opin Ther Targets 2010, 14:603-610.
4. He L., Wang H., Jin H., et al. CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett 2009, 276:88-94.
5. Saito Y., Shibayama H., Tanaka H., Tanimura A., Matsumura I., Kanakura Y. PICOT is a molecule which binds to anamorsin. Biochem Biophys Res Commun 2011, 408:329-333.
6. Saito Y., Shibayama H., Tanaka H., Tanimura A., Kanakura Y. A cell-death-defying factor, anamorsin mediates cell growth through inactivation of PKC and p38MAPK. Biochem Biophys Res Commun 2011, 405:303-307.
7. Zhang Y., Lyver E.R., Nakamaru-Ogiso E., et al. Dre2, a conserved eukaryotic Fe/S cluster protein, functions in cytosolic Fe/S protein biogenesis. Mol Cell Biol 2008, 28:5569-5582.
8. Banci L., Bertini I., Ciofi-Baffoni S., et al. Anamorsin is a [2Fe-2S] cluster-containing substrate of the Mia40-dependent mitochondrial protein trapping machinery. Chem Biol 2011, 18:794-804.
9. Hao Z., Li X., Qiao T., Du R., Hong L., Fan D. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol Ther 2006, 5:261-266.
10. Li X., Hong L., Zhao Y., et al. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Biochem Cell Biol 2007, 85:741-750.
11. Shizusawa T., Shibayama H., Murata S., et al. The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients. Leuk Lymphoma 2008, 49:113-121.
12. Li X., Pan Y., Fan R., et al. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth invitro and invivo. Carcinogenesis 2008, 29:1587-1593.
13. Fujita J., Mizuki M., Otsuka M., et al. Myeloid neoplasm-related gene abnormalities differentially affect dendritic cell differentiation from murine hematopoietic stem/progenitor cells. Immunol Lett 2011, 136:61-73.
14. Muller A.M., Medvinsky A., Strouboulis J., Grosveld F., Dzierzak E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1994, 1:291-301.
15. Medvinsky A., Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996, 86:897-906.
16. Sanchez M.J., Holmes A., Miles C., Dzierzak E. Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo. Immunity 1996, 5:513-525.
17. Wagers A.J. Stem cell grand SLAM. Cell 2005, 121:967-970.
18. Christensen J.L., Weissman I.L. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A 2001, 98:14541-14546.
19. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
20. Torok-Storb B., Iwata M., Graf L., Gianotti J., Horton H., Byrne M.C. Dissecting the marrow microenvironment. Ann N Y Acad Sci 1999, 872:164-170.
21. Wineman J., Moore K., Lemischka I., Muller-Sieburg C. Functional heterogeneity of the hematopoietic microenvironment: rare stromal elements maintain long-term repopulating stem cells. Blood 1996, 87:4082-4090.
22. Xu M.J., Tsuji K., Ueda T., et al. Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines. Blood 1998, 92:2032-2040.
23. Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res 2003, 531:81-92.
24. Zhang K.H., Tian H.Y., Gao X., et al. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res 2009, 69:5340-5348.
25. Yuan X., Cong Y., Hao J., et al. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor. J Mol Biol 2004, 339:131-144.
26. Xie C., Zhang N., Zhou H., et al. Distinct roles of basal steady-state and induced H-ferritin in tumor necrosis factor-induced death in L929 cells. Mol Cell Biol 2005, 25:6673-6681.
27. Ito K., Hirao A., Arai F., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
28. Rouault T.A., Tong W.H. Iron-sulfur cluster biogenesis and human disease. Trends Genet 2008, 24:398-407.
29. Kiel M.J., Morrison S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008, 8:290-301.
30. Li L., Xie T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 2005, 21:605-631.
31. Haug J.S., He X.C., Grindley J.C., et al. N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2008, 2:367-379.
32. Arai F., Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 2007, 1106:41-53.
33. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
34. Fleming H.E., Janzen V., Lo Celso C., et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal invivo. Cell Stem Cell 2008, 2:274-283.
35. Nimer S.D. Myelodysplastic syndromes. Blood 2008, 111:4841-4851.
36. Mufti G.J., Bennett J.M., Goasguen J., et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 2008, 93:1712-1717.
37. Gattermann N. Pathophysiological and clinical aspects of iron chelation therapy in MDS. Curr Pharm Des 2012, 18:3222-3234.
38. Breccia M., Alimena G. Efficacy and safety of deferasirox in myelodysplastic syndromes. Ann Hematol 2013, 92:863-870.
39. Prus E., Fibach E. The labile iron pool in human erythroid cells. Br J Haematol 2008, 142:301-307.
40. Epsztejn S., Kakhlon O., Glickstein H., Breuer W., Cabantchik I. Fluorescence analysis of the labile iron pool of mammalian cells. Anal Biochem 1997, 248:31-40.